BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6804992)

  • 1. Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats.
    Karpen CW; Pritchard KA; Merola AJ; Panganamala RV
    Prostaglandins Leukot Med; 1982 Feb; 8(2):93-103. PubMed ID: 6804992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dietary vitamin E on platelet thromboxane A2 and vascular prostacyclin I2 in rabbit.
    Pritchard KA; Karpen CW; Merola AJ; Panganamala RV
    Prostaglandins Leukot Med; 1982 Oct; 9(4):373-8. PubMed ID: 6757965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacyclin and thromboxane in diabetic children.
    Kaar ML; Kaapa P; Viinikka L; Ylikorkala O
    Prostaglandins Leukot Med; 1983 Jul; 11(3):339-44. PubMed ID: 6351104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboxane A2 and prostacyclin formation in rats fed cod-liver or sunflower oil.
    Nutr Rev; 1982 May; 40(5):157-9. PubMed ID: 6808427
    [No Abstract]   [Full Text] [Related]  

  • 7. Vascular responsiveness and eicosanoid production in diabetic rats.
    Roth DM; Reibel DK; Lefer AM
    Diabetologia; 1983 May; 24(5):372-6. PubMed ID: 6347785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of unsaturated fatty acids on the balance between thromboxane A2 and prostacyclin in the blood vascular system.
    Srivastava KC; Awasthi KK
    Prostaglandins Leukot Med; 1983 Dec; 12(4):449-59. PubMed ID: 6422477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E.
    Karpen CW; Merola AJ; Trewyn RW; Cornwell DG; Panganamala RV
    Prostaglandins; 1981 Oct; 22(4):651-61. PubMed ID: 6798639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating prostacyclin and thromboxane levels in patients with diabetic retinopathy.
    Lane LS; Jansen PD; Lahav M; Rudy C
    Ophthalmology; 1982 Jul; 89(7):763-6. PubMed ID: 6750495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prostacyclin biosynthesis by aortic tissue of the chicken.
    Claeys M; Wechsung E; Herman AG; Nugteren DH
    Prostaglandins; 1981 May; 21(5):739-49. PubMed ID: 6803304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
    Gerrard JM; Stuart MJ; Rao GH; Steffes MW; Mauer SM; Brown DM; White JG
    J Lab Clin Med; 1980 Jun; 95(6):950-8. PubMed ID: 6445927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
    Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of smoking on platelets and on plasma thromboxane-prostacyclin balance in man.
    Mehta P; Mehta J
    Prostaglandins Leukot Med; 1982 Aug; 9(2):141-50. PubMed ID: 6181530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans.
    Faymonville ME; Deby-Dupont G; Larbuisson R; Deby C; Bodson L; Limet R; Lamy M
    J Thorac Cardiovasc Surg; 1986 Jun; 91(6):858-66. PubMed ID: 3520158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2.
    Defreyn G; Deckmyn H; Vermylen J
    Thromb Res; 1982 Jun; 26(6):389-400. PubMed ID: 7051416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of cardiovascular disorders in streptozotocin-induced diabetes in rat. II. Correlation between lipid peroxides, thromboxane A2/prostacyclin, and platelet aggregation in different stages of diabetes.
    Somova L; Kamenov V; Doncheva M; Kirilov G; Vassileva M
    Acta Physiol Pharmacol Bulg; 1988; 14(3):57-62. PubMed ID: 3066112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.